Cargando…

Prediction Score for Antimony Treatment Failure in Patients with Ulcerative Leishmaniasis Lesions

BACKGROUND: Increased rates for failure in leishmaniasis antimony treatment have been recently recognized worldwide. Although several risk factors have been identified there is no clinical score to predict antimony therapy failure of cutaneous leishmaniasis. METHODS: A case control study was conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valencia, Cristian, Arévalo, Jorge, Dujardin, Jean Claude, Llanos-Cuentas, Alejandro, Chappuis, François, Zimic, Mirko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373623/ https://www.ncbi.nlm.nih.gov/pubmed/22720098 http://dx.doi.org/10.1371/journal.pntd.0001656

Ejemplares similares

Quantification of Leishmania (Viannia) Kinetoplast DNA in Ulcers of Cutaneous Leishmaniasis Reveals Inter-site and Inter-sampling Variability in Parasite Load
por: Suárez, Milagros, et al.
Publicado: (2015)

Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis
por: Jara, Marlene, et al.
Publicado: (2023)

A Case–Control Study on the Association Between Intestinal Helminth Infections and Treatment Failure in Patients With Cutaneous Leishmaniasis
por: Martínez, Dalila Y, et al.
Publicado: (2020)

Tegumentary leishmaniasis and coinfections other than HIV
por: Martínez, Dalila Y., et al.
Publicado: (2018)

First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
por: Miranda-Verastegui, Cesar, et al.
Publicado: (2009)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
por: Vargas, Deninson Alejandro, et al.
Publicado: (2019)

Non-Invasive Cytology Brush PCR for the Diagnosis and Causative Species Identification of American Cutaneous Leishmaniasis in Peru
por: Valencia, Braulio Mark, et al.
Publicado: (2012)

Non-Invasive Cytology Brush PCR Diagnostic Testing in Mucosal Leishmaniasis: Superior Performance to Conventional Biopsy with Histopathology
por: Boggild, Andrea K., et al.
Publicado: (2011)

Novel Low-Cost Thermotherapy for Cutaneous Leishmaniasis in Peru
por: Valencia, Braulio M., et al.
Publicado: (2013)

Comparative Gene Expression Analysis throughout the Life Cycle of Leishmania braziliensis: Diversity of Expression Profiles among Clinical Isolates
por: Adaui, Vanessa, et al.
Publicado: (2011)

Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India
por: Stauch, Anette, et al.
Publicado: (2012)

Risk factors for cutaneous leishmaniasis in a high-altitude forest region of Peru
por: Lana, Justin T., et al.
Publicado: (2021)

Risk factors for antimony treatment failure in American Cutaneous Leishmaniasis in Northwestern-Argentina
por: García-Bustos, María F., et al.
Publicado: (2021)

Ramsey hunt syndrome after antimonial treatment for American Cutaneous Leishmaniasis
por: Cavalcante, Melissa de Sousa Melo, et al.
Publicado: (2020)

A novel marker, ARM58, confers antimony resistance to Leishmania spp.()
por: Nühs, Andrea, et al.
Publicado: (2013)

Visceral Leishmaniasis and Arsenic: An Ancient Poison Contributing to Antimonial Treatment Failure in the Indian Subcontinent?
por: Perry, Meghan R., et al.
Publicado: (2011)

IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru
por: Best, Ivan, et al.
Publicado: (2018)

Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
por: Haldar, Arun Kumar, et al.
Publicado: (2011)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis
por: Maristany Bosch, Marta, et al.
Publicado: (2021)

American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure
por: Marques, Sílvio Alencar, et al.
Publicado: (2019)

Leishmania RNA virus-1 is similarly detected among metastatic and non-metastatic phenotypes in a prospective cohort of American Tegumentary Leishmaniasis
por: Valencia, Braulio Mark, et al.
Publicado: (2022)

New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony
por: Shin, Ji Yeon, et al.
Publicado: (2013)

Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden
por: Vanaerschot, Manu, et al.
Publicado: (2011)

Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study
por: Castro, Maria del Mar, et al.
Publicado: (2017)

Parasite hybridization promotes spreading of endosymbiotic viruses
por: Heeren, Senne, et al.
Publicado: (2023)

Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
por: Yazdanpanah, Mohamad Javad, et al.
Publicado: (2011)

RESOLUTION OF CUTANEOUS LEISHMANIASIS AFTER ACUTE ECZEMA DUE TO INTRALESIONAL MEGLUMINE ANTIMONIATE
por: Vasconcellos, Erica de Camargo Ferreira e, et al.
Publicado: (2014)

Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)
por: Gómez, María Adelaida, et al.
Publicado: (2020)

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia
por: Rojas Cabrera, Ernesto, et al.
Publicado: (2022)

Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia
por: Ostyn, Bart, et al.
Publicado: (2014)

Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients
por: de Oliveira Bezerra, Débora Cristina, et al.
Publicado: (2017)

Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment
por: da Silva, Rosiana Estéfane, et al.
Publicado: (2018)

Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
por: Brito, Nayara Castelano, et al.
Publicado: (2017)

The effect of Nd:YAG laser therapy on cutaneous leishmaniasis compared to intralesional meglumine antimoniate
por: Omidian, Mohammad, et al.
Publicado: (2019)

Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline
por: Cincura, Carolina, et al.
Publicado: (2022)

Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review
por: Berbert, Taisa Rocha Navasconi, et al.
Publicado: (2018)

PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
por: LYRA, Marcelo Rosandiski, et al.
Publicado: (2016)

Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial
por: Oliveira, Rodrigo A, et al.
Publicado: (2012)

Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
por: Barros, Andrea Barbieri, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_am0he7clr6vce588nca82nld5u